Tuesday, November 9, 2010

New use of Cymbalta is approved

Welcome back after diwali holidays.. Wish all of you a very happy and prosperous new year ahead..!!!!

The USFDA has approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first approved for its indication for treatment of major depressive disorder.
(Source: www.fda.gov)

No comments:

Post a Comment